Balancing agility and reach, while ensuring operational efficiency and patient-centricity, is no straightforward task in clinical trials. One key enabler in achieving this balance? Finding the right partners – CROs and sites.
Right size of the CROs and right type of the site network working together as partners are able to deliver the clinical trial success through more structured and collaborative approach. From established global site networks like Pratia to growing Site Management Organisations (SMOs) in emerging markets such as Medrial in Armenia, these partnerships are reshaping how CROs and Sponsors approach feasibility, site selection, and geographic diversity.
This webinar brings together expert voices from across these key players in clinical research to discuss how such partnerships are evolving into tailored, strategic collaborations, and how they can help sponsors – pharmaceutical and biotech companies deliver clinical trial success. Whether navigating early-phase oncology studies or scaling large multinational trials, we will examine how aligned goals, specialised expertise and patient-focused models are driving results.
Watch the recording of the panel discussion below to explore:
- How mid-sized CROs partner with site networks to accelerate operations, optimize the costs and reach patients.
- What are the benefits of modern site networks, and the specialised clinical expertise they offer.
- The growing value of SMOs in emerging markets like Armenia, and how they enable trial collaboration and patient access.
- Real-world insights from a Phase I oncology study run within a site network, including takeaways on feasibility and patient voice.
- Why biotech sponsors should re-evaluate their assumptions about site networks from early to late-phase trials.
